Diverse alterations associated with resistance to KRAS(G12C) inhibition
Yulei Zhao(Memorial Sloan Kettering Cancer Center), Yonina R. Murciano‐Goroff(Memorial Sloan Kettering Cancer Center), Jenny Y. Xue(Memorial Sloan Kettering Cancer Center), Agnes Ang(Amgen (United States)), Jessica Lucas(Memorial Sloan Kettering Cancer Center), Trang T. Mai(Memorial Sloan Kettering Cancer Center), Arnaud Da Cruz Paula(Memorial Sloan Kettering Cancer Center), Anne Y. Saiki(Amgen (United States)), Deanna Mohn(Amgen (United States)), Pragathi Achanta(Amgen (United States)), Ann Elizabeth Sisk(Memorial Sloan Kettering Cancer Center), Kanika Arora(Memorial Sloan Kettering Cancer Center), Rohan S. Roy(Cornell University), Dong-Sung Kim(Memorial Sloan Kettering Cancer Center), Chuanchuan Li(Memorial Sloan Kettering Cancer Center), Lee P. Lim, Mark Li, Amber Bahr(Memorial Sloan Kettering Cancer Center), Brian Houck‐Loomis(Memorial Sloan Kettering Cancer Center), Elisa de Stanchina(Memorial Sloan Kettering Cancer Center), Jorge S. Reis-Filho(Memorial Sloan Kettering Cancer Center), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Kathryn C. Arbour(Memorial Sloan Kettering Cancer Center), J. Russell Lipford(Amgen (United States)), Bob T. Li(Memorial Sloan Kettering Cancer Center), Piro Lito(Memorial Sloan Kettering Cancer Center)
Cited by 439Open Access
Abstract
Related Papers
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data